BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10989688)

  • 1. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative.
    Ramirez G; Cabral R; Patterson M; Schoenbachler BT; Bedell D; Smith BD; Vellozzi C; Beckett GA
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):5-11. PubMed ID: 27168655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives.
    Maqsood Q; Sumrin A; Iqbal M; Younas S; Hussain N; Mahnoor M; Wajid A
    Antivir Ther; 2023 Aug; 28(4):13596535231189643. PubMed ID: 37489502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.
    Yao ZQ; Moorman JP
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):193-201. PubMed ID: 23400275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.
    Vladareanu AM; Ciufu C; Neagu AM; Onisai M; Bumbea H; Vintilescu AM; Dobrea C; Arama V; Mihailescu R; Arama S
    J Med Life; 2010; 3(3):320-9. PubMed ID: 20945824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection.
    Hsu TC; Tsay GJ; Chen TY; Liu YC; Tzang BS
    Clin Exp Immunol; 2006 Apr; 144(1):110-6. PubMed ID: 16542372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
    Park H; Jeong D; Nguyen P; Henry L; Hoang J; Kim Y; Sheen E; Nguyen MH
    PLoS One; 2018; 13(4):e0196452. PubMed ID: 29708985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of coinfection by schistosomiasis and viral hepatitis B or C using 1H NMR-based metabonomics.
    Gouveia LR; Santos JC; Silva RD; Batista AD; Domingues ALC; Lopes EPA; Silva RO
    PLoS One; 2017; 12(8):e0182196. PubMed ID: 28763497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis Status and its Effect upon the Progression of Chronic Kidney Disease: Presentations, Associations and Complications.
    AlMaawali S; Al Salmi I; Al-Darmaki A; Al-Ghonaim M; Hannawi S
    Saudi J Kidney Dis Transpl; 2022; 33(4):543-552. PubMed ID: 37929547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological study of the hepatitis C virus in our population and vaccine coverage].
    Martínez Adell MA; Vives Argilagós A; Sibera Aresté FX; Navarrete Durán P; Barro Lugo S; Urbina García P
    Aten Primaria; 2003 Apr; 31(7):428-32. PubMed ID: 12735885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Parkinson's disease in hepatitis B and C populations: a systematic review and meta-analysis.
    Yaow CYL; Hong ASY; Chong NZ; Chong RIH; Mai AS; Tan EK
    J Neural Transm (Vienna); 2023 Oct; ():. PubMed ID: 37899363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on hepatitis B and C virus diagnosis.
    Villar LM; Cruz HM; Barbosa JR; Bezerra CS; Portilho MM; Scalioni Lde P
    World J Virol; 2015 Nov; 4(4):323-42. PubMed ID: 26568915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biobanking for Viral Hepatitis Research.
    Ho E; Van Hees S; Goethals S; Smits E; Huizing M; Francque S; De Winter B; Michielsen P; Vanwolleghem T
    Front Med (Lausanne); 2019; 6():183. PubMed ID: 31482092
    [No Abstract]   [Full Text] [Related]  

  • 13. Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?
    Anugwom CM; Aby ES; Debes JD
    Clin Infect Dis; 2021 Jan; 72(1):180-182. PubMed ID: 32502247
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a catch-up strategy for the vaccination in patients with hepatitis C virus.
    Fernández-Prada M; Fraga-Pérez A; Cienfuegos-González P; Zapico-Baragaño MJ; Brea-Corral JM; Huergo-Fernández A
    Rev Esp Enferm Dig; 2024 Mar; ():. PubMed ID: 38501772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.
    Nguyen MH; Wong G; Gane E; Kao JH; Dusheiko G
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult HBV infection among Egyptian hepatocellular carcinoma patients.
    Hassan ZK; Hafez MM; Mansor TM; Zekri AR
    Virol J; 2011 Mar; 8():90. PubMed ID: 21371325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
    Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
    Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatic porphyria and hepatitis B and C virus infections].
    Malina L; Stránský J; Havlícková M; Zd'árský E
    Cas Lek Cesk; 1998 Sep; 137(18):561-4. PubMed ID: 9818466
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.